You are here: Industry Insights > COVID-19

News List

India to set up $1.3bn pharma manufacturing fund, says report europeanpharmaceuticalreview
March 26, 2020
Due to the COVID-19 outbreak, India has decided to invest $1.3 billion into its internal drug manufacturing capabilities, says a new report.
Covid-19 triggers 20% drop in oil demand pharmaceutical-technology
March 26, 2020
Early figures are suggesting that the outbreak of Covid-19 could have a significant impact on global oil demand, with Arij van Berkel。
Gilead Requests Retraction of Orphan Designation for Remdesivir contractpharma
March 26, 2020
Seeks to waive all benefits amid growing concerns the specialty status could impact pricing and availability of competitor products.
Bengal Chemicals can supply only 10 lakh hydroxy-chloroquine tablets expresspharma
March 26, 2020
PSU pharma company Bengal Chemicals and Pharmaceuticals said it can provide only a maximum of 10 lakh hydroxy-chloroquine tablets due to the shortage of a key component.
SonoScape Shares its Experience of Fighting Against COVID-19 to the Global Community prnasia
March 25, 2020
SonoScape, one of the leading providers of ultrasound and endoscopy solutions, headquartered in Shenzhen China, started to help with the coronavirus epidemic as early as in January.
Sinopec Joins Global Fight Against COVID-19, Shipping Over 10,000 Tonnes of Disinfectant prnasia
March 25, 2020
As the world battles the COVID-19 pandemic, Sinopec Corp (HKG: 0386), China's leading energy and chemical company, has shown support and solidarity to the international community by supplying 10,256 tonnes of much-needed bleaching powder to countries grap
ixlayer Launches COVID-19 Clinical Testing Platform to Power Labs and Health Systems prnasia
March 25, 2020
ixlayer, an industry leader in technology solutions for health testing, has adapted its platform to address the need to rapidly launch and scale COVID-19 clinical testing.
Happiness Biotech Announced Breakthrough in Developing Covid-19 Testing Kits prnasia
March 25, 2020
Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company, together with Fuzhou University, have achieved a breakthrough in developing Covid-
COVID-19: NIHR awards £10.5m to six new projects as NHS receives more protective equipment pharmatimes
March 25, 2020
In the latest ongoing efforts to protect the UK’s healthcare system against the potentially devastating effects of COVID-19 (coronavirus) ...
FDA approves COVACTA trial for RA drug Actemra in COVID-19 patients pharmaceutical-business-review
March 25, 2020
Genentech has secured approval in the US to go ahead with the COVACTA trial to assess the use of its rheumatoid arthritis drug (RA drug) Actemra (tocilizumab) in COVID-19 patients.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page